Prosecution Insights
Last updated: August 18, 2026

Examiner: THOMAN, EVELYN ANNE

Tech Center 3700 • Art Units: 3783

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-70.0% vs TC avg
20
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
10.0%
§102 Novelty
58.8%
§103 Obviousness
25.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18179656 MALE LUER CONNECTOR Non-Final OA CareFusion 303, Inc.
17856855 MEDICAL DEVICE WITH ADAPTIVE CORRECTION FOR UNCONTROLLABLE DELIVERY CONDITIONS Non-Final OA CareFusion 303, Inc.
18752565 REMOVABLE LUNG ISOLATION DEVICE FOR LOCALIZED DRUG THERAPY Non-Final OA Covidien LP
18684061 THERAPEUTIC AGENT DELIVERY DEVICE WITH USER INPUT Non-Final OA ELI LILLY AND COMPANY
18257487 FLUID DELIVERY SYSTEM WITH NEEDLE ASSEMBLY Non-Final OA Eli Lilly and Company
18765795 INTACT PILL DELIVERY SYSTEM Non-Final OA The Regents of the University of Colorado, a body corporate
18190572 AUTONOMOUS ADAPTIVITY AND SET POINT CONTROL FOR A DRUG DELIVERY DEVICE Final Rejection INSULET CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month